Published on October 6, 2026 in Nature Medicine, the founding paper of MAGIC announces an international network designed to develop a more representative evaluation of generative AI in healthcare. Its goal is to move beyond…
In 2026, several clinical studies evaluated artificial intelligence in breast cancer screening, going beyond retrospective testing alone. The randomized MASAI trial reports fewer cancers detected between two screening rounds, while other studies show possible gains…
Launched by Google DeepMind on September 8, 2026, AlphaGenome Atlas makes available predictions of the molecular effects of nine billion possible single-letter substitutions in the human genome. These are neither nine billion mutations observed in…
Neuroscience News